Publication | Closed Access

Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase

Mining Therapeutic TargetsVirtual ScreeningEngineeringAntimicrobial SusceptibilityAntimicrobial Resistance GeneMedicineBiotechnologySynthetic BiologyAntibacterial AgentMicrobiologyAntibiotic ResistanceAntimicrobial CompoundRiboflavin SynthasePharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance